INITIAL COSTS OF TREATMENT AMONG STAGE IV PROSTATE CANCER (PCA) CHEMOTHERAPY PATIENTS IN SEER-MEDICARE

被引：0
|
作者：
Onukwugha, E.
Mullins, C. D. [1 ]
Seal, B. [2 ]
Hussain, A. [3 ]
机构：
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[2] Sanofi Aventis Pharmaceut, Bridgewater, NJ USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72132-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
  • [1] Who receives chemotherapy: An analysis of stage IV prostate cancer (PCa) patients in SEER-Medicare
    Grabner, M.
    Onukwugha, E.
    Mullins, C. D.
    Seal, B. S.
    Hussain, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Radiation oncologist visits and the effect on prostate cancer (PCa) survival among SEER-Medicare patients with stage IV disease.
    Onukwugha, E.
    Mullins, C. D.
    Grabner, M.
    Hussain, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] PHYSICIAN REFERRAL PATTERNS AMONG ELDERLY PATIENTS WITH STAGE IV PROSTATE CANCER (PCA): AN ANALYSIS USING SEER-MEDICARE DATA
    Onukwugha, E. E.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2009, 12 (03) : A54 - A55
  • [4] TIMING OF PHYSICIAN VISITS AND THE IMPACT ON SURVIVAL AMONG SEER-MEDICARE PATIENTS WITH STAGE IV PROSTATE CANCER
    Onukwugha, E. E.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2009, 12 (03) : A38 - A38
  • [5] Patterns of use of docetaxel in stage IV prostate cancer (PCa) patients in SEER-Medicare.
    Onukwugha, E.
    Grabner, M.
    Mullins, C. D.
    Seal, B. S.
    Hussain, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] COST ANALYSIS OF SKELETAL RELATED EVENTS AMONG ELDERLY MEN WITH STAGE IV METASTATIC PROSTATE CANCER IN SEER-MEDICARE
    Jayasekera, J.
    Onukwugha, E.
    Mullins, C. D.
    Seal, B.
    Bikov, K.
    Hussain, A.
    VALUE IN HEALTH, 2013, 16 (03) : A136 - A136
  • [7] OUTCOMES AND COSTS FOLLOWING TREATMENT FOR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM SEER-MEDICARE
    Sussman, Rachael
    Harbin, Andrew
    Lynch, John
    Hu, Jim
    Kowalczyk, Keith
    JOURNAL OF UROLOGY, 2015, 193 (04): : E150 - E150
  • [8] The impact of time of medical oncologist visit on survival among elderly patients with stage IV prostate cancer: An analysis using SEER-Medicare data
    Mullins, C. D.
    Onukwugha, E.
    Seal, B.
    Hussain, A.
    Hussain, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data
    Raab, Gabriel T.
    Lin, Aijing
    Hillyer, Grace Clarke
    Keller, Deborah
    O'Neil, Daniel S.
    Accordino, Melissa Kate
    Buono, Donna L.
    Hur, Chin
    Kiran, Ravi P.
    Wright, Jason D.
    Hershman, Dawn L.
    Neugut, Alfred I.
    CLINICAL COLORECTAL CANCER, 2019, 18 (03) : E294 - E299
  • [10] Characteristics of stage III and IV M0 prostate cancer (PCa) patients in SEER-Medicare who develop bone metastasis (BM) following diagnosis.
    Hussain, Arif
    Onukwugha, Ebere
    Jayasekera, Jinani
    McNally, Diane L.
    Seal, Brian S.
    Mullins, C. Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345